Synopsis
Synopsis
0
VMF
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Mls001401438
2. Chembl1895091
3. Hms2051p14
4. Hms2233m10
5. Ccg-101038
6. Nc00288
7. Smr000471620
Molecular Weight | 478.5 g/mol |
---|---|
Molecular Formula | C23H30N2O9 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 10 |
Exact Mass | 478.19513054 g/mol |
Monoisotopic Mass | 478.19513054 g/mol |
Topological Polar Surface Area | 166 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 507 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
Patent Expiration Date : 2031-03-17
BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
US Patent Number : 8815258
Drug Substance Claim :
Drug Product Claim :
Application Number : 212122
Patent Use Code : U-2889
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-17
Patent Expiration Date : 2029-04-07
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE
US Patent Number : 8616196
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21929
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-04-07
Patent Expiration Date : 2038-10-05
BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
US Patent Number : 11331442
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212122
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-10-05
Patent Expiration Date : 2026-04-10
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE
US Patent Number : 7587988
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21929
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-04-10
Patent Expiration Date : 2029-04-16
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE
US Patent Number : 8528545*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 21929
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-04-16
Patent Expiration Date : 2031-03-17
FORMOTEROL FUMARATE; GLYCOPYRROLATE
US Patent Number : 8815258
Drug Substance Claim :
Drug Product Claim :
Application Number : 208294
Patent Use Code : U-2889
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-17
Patent Expiration Date : 2027-03-26
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE
US Patent Number : 8387615
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 21929
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-03-26
Patent Expiration Date : 2029-04-16
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE
US Patent Number : 8528545*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 21929
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-04-16
Patent Expiration Date : 2030-05-28
FORMOTEROL FUMARATE; GLYCOPYRROLATE
US Patent Number : 9463161
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208294
Patent Use Code : U-2889
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-05-28
Patent Expiration Date : 2029-03-13
ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE
US Patent Number : 10085974
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210595
Patent Use Code : U-2513
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-13
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?